Lactobacillus rhamnosus GG ATCC 53103

BIOLOGICAL2 trials

Sponsors

Massachusetts General Hospital, San Giovanni Addolorata Hospital

Conditions

HealthyUlcerative Colitis Chronic MildUlcerative Colitis Chronic Moderate

Phase 1

Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) in Healthy Volunteers

CompletedNCT00934453

Massachusetts General HospitalHealthy

Start: 2009-12-31End: 2012-05-31Updated: 2017-01-11

Lactobacillus Rhamnosus GG (ATCC 53103) in Mild-moderately Active UC Patients

CompletedNCT04102852

San Giovanni Addolorata HospitalUlcerative Colitis Chronic Mild, Ulcerative Colitis Chronic Moderate

Start: 2019-09-30End: 2022-01-31Updated: 2022-10-26

Related Papers

Safety and Potential Role of Lactobacillus rhamnosus GG Administration as Monotherapy in Ulcerative Colitis Patients with Mild–Moderate Clinical Activity

Microorganisms2023-05-2419 citations